Skip to main content
Clinical Trials/CTRI/2012/05/002627
CTRI/2012/05/002627CompletedPhase 1/2

A Prospective, Multicentric, Open Label, Bio-Interventional, Phase I/II Pilot Study To Evaluate The Safety And Efficacy Of Autologous Human Platelet Lysate (HPL) For Treatment of Facial Wrinkles (Nasolabial Folds)

KASIAK RESEARCH PRIVATE LIMITED2 sites in 1 country20 target enrollmentStarted: April 17, 2012Last updated:
Conditions

Trial Snapshot

Phase
Phase 1/2
Status
Completed
Sponsor
Enrollment
20
Locations
2
Primary Endpoint
•Wrinkle Severity Rating Scale ( WSRS ) as per ATLAS photographic grading at rest

Study Overview

Brief Summary

This is a multicentre, open label, pilot study to evaluate safety and efficacy of Autologous Human Platelet Lysate (HPL) in subjects with Facial Wrinkles (Nasolabial Folds). The study is being conducted at 2 centers in India. The primary endpoints are Improvement in  Wrinkle Severity Rating Scale ( WSRS ) as per ATLAS photographic grading at rest and on full smile and   Global Aesthetic Improvement Scale (GAIS ) . The secondary endpoints are improvement in photographic assessment,   Physician’s assessment scores,  Patient’s assessment scores form enrollment to end of study.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18.00 Year(s) to 40.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • •1.Subjects (male and female), aged 18 to 40 years (both inclusive).
  • •2.Subjects willing to refrain from any other treatment for Nasolabial Folds.
  • •3.Subjects who are willing to give informed consent and adhere to the study protocol.

Exclusion Criteria

  • •1.Subjects receiving any aesthetic facial therapy 6 months prior to enrolment e.g. Botox, Fillers etc 2.Subjects with history of Connective tissue disease
  • •Subjects with autoimmune diseases
  • •Subjects unwilling to or unable to comply with the study protocol.
  • •5.Subjects taking concomitant therapy that might interfere with the study results in the investigator’s opinion or participating in another trial in the past 30days.

Outcomes

Primary Outcomes

•Wrinkle Severity Rating Scale ( WSRS ) as per ATLAS photographic grading at rest

Time Frame: End of Study - 3 Months

•Global Aesthetic Improvement Scale (GAIS )

Time Frame: End of Study - 3 Months

•Wrinkle Severity Rating Scale ( WSRS ) as per ATLAS photographic grading on full smile

Time Frame: End of Study - 3 Months

Secondary Outcomes

  • •Photographic Assessment(•Physician’s assessment scores)

Investigators

Sponsor
KASIAK RESEARCH PRIVATE LIMITED
Sponsor Class
Other [Biotechnology company]

Study Sites (2)

Loading locations...

Similar Trials